Evidence map›Paper›PMID 42505900›Full record

ArticleJournal of cardiovascular development and disease2026

Combination of TAPSE/sPAP Ratio and Myocardial Work to Assess Prognosis in Patients with Pulmonary Arterial Hypertension.

Jian Wang, Yingying Xu, Zhenwei Li, Hanbin Cui

Abstract read
In one paragraph

Article in Journal of cardiovascular development and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jian WangDepartment of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo 315000, China.ORCID 0009-0003-6627-6202
Yingying XuDepartment of Intensive Care Unit, The First Affiliated Hospital of Ningbo University, Ningbo 315000, China.
Zhenwei LiDepartment of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo 315000, China.
Hanbin CuiDepartment of Cardiology, The First Affiliated Hospital of Ningbo University, Ningbo 315000, China.

Funding

Chinese Medicine and Health Science and Technology Program of Zhejiang Province 2024ZL146the Major Project of Science and Technology Innovation 2025 in Ningbo, China 2021Z134
6 · The paper itself

Abstract

objectivePulmonary arterial hypertension (PAH) is a progressive disease leading to right ventricular (RV) hypertrophy and failure. This study aims to evaluate the prognostic value of combining the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure (TAPSE/sPAP) ratio with right ventricular myocardial work (RVMW) parameters in patients with PAH, to improve early risk stratification.

methodsA total of 43 PAH patients diagnosed via right heart catheterization were enrolled. Echocardiography-derived TAPSE/sPAP ratio and RVMW parameters, including right ventricular global work efficiency (RVGWE), global work index (RVGWI), global constructive work (RVGCW), and global wasted work (RVGWW), were measured. Clinical worsening events were recorded during a median 515-day follow-up. Statistical analyses included correlation tests, Firth penalized logistic regression, receiver operating characteristic (ROC) curves, and Kaplan-Meier survival analysis.

resultsThe TAPSE/sPAP ratio correlated negatively with RVGCW (r = -0.346,

conclusionNon-invasive assessment of TAPSE/sPAP ratio and RVGWE provides significant prognostic value in PAH. Their combination enhances early risk prediction, offering a practical tool for clinical management.

Indexed as

echocardiographyprognosispulmonary arterial hypertensionright ventricular myocardial workTAPSE/sPAP ratio

Identifiers

PMID42505900
PMCPMC13411884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.